Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome

References

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. J Am Med Assoc 2006;295:1549–55.10.1001/jama.295.13.1549Search in Google Scholar PubMed

2. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005;46:871–80.10.1053/j.ajkd.2005.08.015Search in Google Scholar PubMed

3. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21–8.10.7326/0003-4819-144-1-200601030-00006Search in Google Scholar PubMed

4. Hunley TE, Ma LJ, Kon V. Scope and mechanisms of obesity-related renal disease. Curr Opin Nephro Hypertens 2010;19: 227–34.10.1097/MNH.0b013e3283374c09Search in Google Scholar PubMed PubMed Central

5. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006;17:1695–702.10.1681/ASN.2005060638Search in Google Scholar PubMed

6. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. J Am Med Assoc 2004;291:844–50.10.1001/jama.291.7.844Search in Google Scholar PubMed

7. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004;65:1870–6.10.1111/j.1523-1755.2004.00582.xSearch in Google Scholar PubMed

8. Fu CP, Lee IT, Sheu WH, Lee WJ, Liang KW, Lee WL, et al. The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men. Clin Chimica Acta 2012;413:1647–51.10.1016/j.cca.2012.05.008Search in Google Scholar PubMed

9. Bolignano D, Zoccali C. Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant 2013;28(Suppl 4):iv82–98.10.1093/ndt/gft302Search in Google Scholar PubMed

10. Chang A, Batch BC, McGuire HL, Vollmer WM, Svetkey LP, Tyson CC, et al. Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study. Am J Kidney Dis 2013;62:900–7.10.1053/j.ajkd.2013.04.022Search in Google Scholar PubMed PubMed Central

11. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol 2013;33:14–22.10.1016/j.semnephrol.2012.12.006Search in Google Scholar PubMed

12. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Inter J Obes 2005;29:146–50.10.1038/sj.ijo.0802839Search in Google Scholar PubMed

13. Schernthaner GH, Kopp HP, Kriwanek S, Krzyzanowska K, Satler M, Koppensteiner R, et al. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity. Obes Surg 2006;16:709–15.10.1381/096089206777346763Search in Google Scholar PubMed

14. Barrera-Chimal J, Bobadilla NA. Are recently reported biomarkers helpful for early and accurate diagnosis of acute kidney injury? Biomarkers 2012;17:385–93.10.3109/1354750X.2012.680070Search in Google Scholar PubMed

15. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 2013;28:254–73.10.1093/ndt/gfs380Search in Google Scholar PubMed

16. Parikh CR, Lu JC, Coca SG, Devarajan P. Tubular proteinuria in acute kidney injury: a critical evaluation of current status and future promise. Ann Clin Biochemi 2010;47:301–12.10.1258/acb.2010.010076Search in Google Scholar PubMed

17. Bosomworth MP, Aparicio SR, Hay AW. Urine N-acetyl-beta-D-glucosaminidase – a marker of tubular damage? Nephrol Dial Transplant 1999;14:620–6.10.1093/ndt/14.3.620Search in Google Scholar PubMed

18. Guder WG, Hofmann W. Markers for the diagnosis and monitoring of renal tubular lesions. Clin Nephrol 1992;38(Suppl 1):S3–7.Search in Google Scholar

19. Watts GF, Vlitos MA, Morris RW, Price RG. Urinary N-acetyl-beta-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control. Diabete Metab 1988;14:653–8.Search in Google Scholar

20. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.10.1161/circ.106.25.3143Search in Google Scholar

21. Harris JA, Benedict FG. Standard basal metabolism constants for physiologists and clinicians. In: Harris JA, Benedict FG, editors. A biometric study of basal metabolism in man. Publication 279, The Carnegie Institute of Washington. Philadelphia, PA: JB Lippincott, 1919.Search in Google Scholar

22. World Health Organization. WHO/FAO/UNO report: energy and protein requirements. WHO Technical Report Series, No. 724. Geneva, Switzerland: WHO, 1985.Search in Google Scholar

23. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. National Institutes of Health. Obes Res 1998;6(Suppl 2): 51S–209S.Search in Google Scholar

24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Search in Google Scholar PubMed

25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461–70.10.7326/0003-4819-130-6-199903160-00002Search in Google Scholar PubMed

26. Sledzinski T, Proczko-Markuszewska M, Kaska L, Stefaniak T, Swierczynski J. Serum cystatin C in relation to fat mass loss after bariatric surgery. Pol Przegl Chir 2012;84:202–7.10.2478/v10035-012-0033-0Search in Google Scholar PubMed

27. Bueter M, Dubb SS, Gill A, Joannou L, Ahmed A, Frankel AH, et al. Renal cytokines improve early after bariatric surgery. Br J Surg 2010;97:1838–44.10.1002/bjs.7264Search in Google Scholar PubMed

28. Friedman AN, Chambers M, Kamendulis LM, Temmerman J. Short-term changes after a weight reduction intervention in advanced diabetic nephropathy. Clin J Am Soc Nephrol 2013;8:1892–8.10.2215/CJN.04010413Search in Google Scholar PubMed PubMed Central

29. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416–21.10.1111/j.1523-1755.2004.00517.xSearch in Google Scholar PubMed

30. Urbonaviciene G, Shi GP, Urbonavicius S, Henneberg EW, Lindholt JS. Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atherosclerosis 2011;216:440–5.10.1016/j.atherosclerosis.2011.02.016Search in Google Scholar PubMed PubMed Central

31. Kern EF, Erhard P, Sun W, Genuth S, Weiss MF. Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT). Am J Kidney Dis 2010;55:824–34.10.1053/j.ajkd.2009.11.009Search in Google Scholar PubMed PubMed Central

32. Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-beta-D-glucosaminidase. Kidney Int 2011;79:464–70.10.1038/ki.2010.404Search in Google Scholar PubMed PubMed Central

33. Lazarevic G, Antic S, Vlahovic P, Djordjevic V, Zvezdanovic L, Stefanovic V. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients. Ren Fail 2007;29:199–205.10.1080/08860220601098870Search in Google Scholar PubMed

34. Nakano R, Kurosaki E, Shimaya A, Kajikawa S, Shibasaki M. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction. Eur J Pharmacol 2006;549:185–91.10.1016/j.ejphar.2006.08.032Search in Google Scholar PubMed

35. Sato N, Kaneko M, Tamura M, Kurumatani H. The prostacyclin analog beraprost sodium ameliorates characteristics of metabolic syndrome in obese Zucker (fatty) rats. Diabetes 2010;59:1092–100.10.2337/db09-1432Search in Google Scholar PubMed PubMed Central

36. Dominguez JH, Tang N, Xu W, Evan AP, Siakotos AN, Agarwal R, et al. Studies of renal injury III: lipid-induced nephropathy in type II diabetes. Kidney Int 2000;57:92–104.10.1046/j.1523-1755.2000.00814.xSearch in Google Scholar PubMed

37. Dominguez JH, Wu P, Hawes JW, Deeg M, Walsh J, Packer SC, et al. Renal injury: similarities and differences in male and female rats with the metabolic syndrome. Kidney Int 2006;69:1969–76.10.1038/sj.ki.5000406Search in Google Scholar PubMed

38. Dominguez J, Wu P, Packer CS, Temm C, Kelly KJ. Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy. Am J Physiol Ren Physiol 2007;293:F670–9.10.1152/ajprenal.00021.2007Search in Google Scholar PubMed

39. Dominguez JH, Mehta JL, Li D, Wu P, Kelly KJ, Packer CS, et al. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations. Am J Physiol Ren Physiol 2008;294:F110–9.10.1152/ajprenal.00013.2007Search in Google Scholar PubMed

40. Bolignano D, Zoccali C. Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant 2013;28(Suppl 4):iv82–98.10.1093/ndt/gft302Search in Google Scholar PubMed

41. Afshinnia F, Wilt TJ, Duval S, Esmaeili A, Ibrahim HN. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010;25:1173–83.10.1093/ndt/gfp640Search in Google Scholar PubMed

42. Gilardini L, Zulian A, Girola A, Redaelli G, Conti A, Invitti C. Predictors of the early impairment of renal disease in human obesity. Int J Obes (Lond) 2010;34:287–94.10.1038/ijo.2009.227Search in Google Scholar PubMed